Published online before print January 23, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


* Institute of Medical Immunology, Humboldt-University (Charite) Berlin, Germany; and
The Center for Medical Research, University of Western Australia, The Western Australian Institute for Medical Research, Sir Charles Gairdner Hospital, Nedlands, Perth, Australia
1Correspondence at present address: Department of Biochemistry, Trinity College, College Green, Dublin 2, Ireland. E-mail: schrodem{at}tcd.ie
|
|
|---|
Key Words: cytokine signal transduction dimerization signal transducer and activator of transcription (STAT) energy transfer BRET
|
|
|---|
It has been described that not only the SH2 domain but also the N-terminal domain of the STATs are required for receptor binding [8 , 9 ], and very recently Zhang et al. [10 ] proposed an intramolecular interaction between the C- and the N-terminal domains of STATs, which is necessary for receptor binding. These observations queried the conventional model of STAT activation and evoked the need for further investigations.
Bioluminescence resonance energy transfer (BRET) is a recently developed method to investigate proteinprotein interactions in living mammalian cells. BRET takes advantage of a natural phenomenon, namely the Förster energy transfer between a light-emitting luciferase and an acceptor fluorophore. A bioluminescent luciferase [Renilla luciferase (Rluc)] is fused to one of the proteins of interest and a green fluorescent protein [enhanced yellow fluorescent protein (EYFP)] to the other. In the presence of its substrate, Rluc emits light (
max 480 nm), which excites the acceptor fluorophore EYFP, if the two molecules are close enough for energy transfer to occur. It is important to note that those do not naturally associate with each other [11
]. An interaction between the two fusion proteins should bring the luciferase and EYFP close enough for energy transfer to occur. By means of this method, protein interactions can be detected in living cells and be followed over a time-course or under varying conditions. BRET has been successfully used to investigate membrane receptor dimerization and has proven its suitability to detect existing protein interactions [12
13
14
].
We used the BRET assay to investigate the association of STAT3 molecules before and after activation. For the first time, we detected an interaction of nonphosphorylated STAT molecules in living cells. Furthermore, our experiments may allow some conclusions about the structure of the cytoplasmic-preassociated STAT molecules, suggesting a reorganization of the STAT dimers after activation.
|
|
|---|
Plasmid construction
The BRET expression vectors are based on the pcDNA3.1 vector containing the open reading frame for EYFP or for Rluc [14
]. We inserted the complete coding sequences of STAT3 or STAT6 in a way that led to the expression of N-terminal or C-terminal fusion proteins with EYFP or Rluc. The inserts were generated by polymerase chain reaction amplification from IMAGE_3347434 clone (STAT3) or IMAGE_2958389 clone (STAT6; rzpd, Berlin, Germany) using mutagenic primers introducing the appropriate restriction sites.
Western blotting
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting were performed using standard procedures. The phosphorylated form of the STAT3 fusion protein was detected with phospho-specific antibodies against STAT3Tyr705 (Cell Signaling Technology, Beverly, MA).
BRET assay
COS-1 cells were transfected with the RlucSTAT3 protein alone or in combination with EYFP or the STAT3EYFP fusion protein. Transfections were performed using the Superfect® reagent (Qiagen, Valencia, CA) according to the manufacturers recommendations. Total plasmid DNA (3 µg) was used for transfection, and the empty vector was used to equalize DNA amounts in each sample. After 48 h, cells were harvested, washed twice with phosphate-buffered saline, and used for BRET analysis. Flow cytometric analysis was performed to check for comparable EYFP expression of EYFP and the EYFPSTAT3 fusion protein.
Approximately 50,000 cells/well were distributed in a 96-well plate, the cell-permeable Rluc substrate coelenterazine (h form; Molecular Probes, Eugene, OR) was added to a final concentration of 5 µM, and readings were collected immediately following this addition. Repeated readings were taken for at least 510 min using a custom-designed BRET instrument (Berthold, Australia), which allows for sequential integration of the signals detected in the 440500 and 510590 nm windows. Human recombinant epidermal growth factor (EGF; Promega, Annandale, Australia) was added to a concentration of 100 ng/ml to activate STAT3, and readings were collected for another 1020 min afterwards. Data were analyzed as a normalized BRET ratio, which is defined as the BRET ratio for the coexpression of the Rluc and EYFP constructs normalized against the BRET ratio for the Rluc expression construct alone.
To quantify the BRET signal generated, the ratio of the light emitted by the EYFP fusion protein (510590 nm) over that emitted by the Rluc fusion protein (440500 nm) was determined by using the following equation [12 ]: [(emission at 510590 nm)(emission at 440500 nm)xcf]/(emission at 440500 nm). cf corresponds to (emission at 510590 nm/emission at 440500 nm) for the Rluc construct expressed alone in the same experiment.
|
|
|---|
110 Å [7
], and the critical Förster radius for energy transfer is
50 Å [15
], we also fused Rluc N-terminally to the STAT3 molecule (RlucSTAT3). Thereby, we hoped to detect interactions independent of the orientation of the STAT3 molecules in the dimer/multimer.
EGF rapidly phosphorylates the STAT3Rluc fusion protein
We aimed at investigating the interaction between STAT3 molecules in the nonactivated state as well as after tyrosine phosphorylation. It has been reported previously that EGF is able to efficiently induce tyrosine phosphorylation of transfected STAT3 in COS-1 cells [9
]. These cells also have reported low levels of endogenous STAT molecules, which is additionally convenient for our analysis, as high levels of endogenous STAT3 might lower the obtained energy transfer signal by forming dimers with fusion proteins, sequestering them in non-BRETting complexes. When we stimulated our transfected COS-1 cells with 100 ng/ml recombinant human EGF we were able to induce a strong, rapid, and lasting tyrosine phosphorylation of the STAT3Rluc fusion protein, which we detected by Western blotting with phospho-specific antibodies against Tyr705 of STAT3 (Fig. 1
).
![]() View larger version (22K): [in a new window] |
Figure 1. COS-1 cells transfected with STAT3Rluc were stimulated for the time periods indicated with 100 ng/ml human recombinant EGF. Cells were then lysed and subjected to Western blot analysis. Phosphorylated fusion protein was detected with a phospho-specific antibody for STAT3 and identified by its molecular weight.
|
![]() View larger version (9K): [in a new window] |
Figure 2. (A) The C-terminal fusion protein STAT3Rluc (0.5 µg) was transfected alone or in combination with the C-terminal fusion protein STAT3EYFP (2 µg), EYFP (1 µg), or STAT6EYFP (2 µg) into COS-1 cells. Cells were harvested 48 h post-transfection, and the BRET assay was performed at 37°C. Ten repetitive readings were collected, and an average of the normalized BRET ratio is depicted in this diagram. Shown is one representative experiment out of four. (B) The N-terminal fusion protein RlucSTAT3 (1.5 µg) was transfected alone or with the above-mentioned constructs into COS-1 cells. The assay was performed as described above.
|
For the combination of the two C-terminal constructs (STAT3Rluc and STAT3EYFP) the signal remained unchanged after addition of EGF (Fig. 3A ).
![]() View larger version (15K): [in a new window] |
Figure 3. (A) The C-terminal fusion protein STAT3Rluc (0.5 µg) was transfected alone or in combination with the C-terminal fusion protein STAT3EYFP (2 µg) into COS-1 cells. Cells were harvested 48 h post-transfection, EYFP expression was checked by flow cytometry, and the BRET assay was performed at 37°C. Ten repetitive readings were collected (approximately 10 min) before addition of EGF. Cells were then incubated for 5 min at 37°C to achieve tyrosine phosphorylation of STAT3, before 15 more readings were collected. The column diagram depicts the normalized BRET ratios before (gray column) and after addition of EGF (black column). (B) The N-terminal fusion protein RlucSTAT3 (1.5 µg) was transfected alone or with the above-mentioned constructs into COS-1 cells. The assay was performed as described above.
|
|
|
|---|
There are also at least two reports in the literature, which would suggest that STATs bind to the activated cytokine receptors in a dimeric rather than the monomeric form suggested by the current model of STAT activation. Behrmann et al. [17 ] demonstrated that a single STAT-binding site in a chimeric receptor complex is sufficient to activate STATs. In a very interesting study, the group of Sidney Pestka [18 ] used the FRET technique to demonstrate that interferon receptors are preassembled on the cell surface and that their intracellular domains move apart upon ligand binding. This might allow for the binding of a STAT dimer in the groove between the two receptor chains. We included this hypothesis into the new model of STAT activation that we suggest below.
We made the surprising observation that the BRET signal decreased after activation when Rluc was fused to the N-terminus of one, and EYFP was fused to the C-terminus of the other STAT3 molecule. This decrease was not observed when EYFP and Rluc were fused to the respective C-termini. We cannot exclude that this different behavior is simply caused by different properties of the luciferase constructs, such as a decreased stability of the RlucSTAT3 protein. Furthermore, RET is not only dependent on the distance between the two fusion proteins but also on their proper orientation to each other. It is therefore thinkable that binding to the DNA or interaction with other proteins influences the orientation of the tag in the N-terminal but not the C-terminal fusion protein and reduces the ability of the former to elicit energy transfer.
Keeping these reservations in mind, we wondered whether our observation could also be explained by assuming qualitative differences between the cytoplasmic STAT3 associates (before activation) and the nuclear STAT3 dimer, which forms after activation.
From the crystal structure of the nuclear STAT3 dimer, it has been determined that the C-termini are very close together, the N-termini stretch apart, and each N-terminal domain alone spans
80 Å [7
]. Therefore, it would be plausible and in accordance with our results, that BRET occurs more efficiently when both tags are fused to the C-termini than when one is fused to the C-terminus and one to the N-terminus (Fig. 4
).
![]() View larger version (19K): [in a new window] |
Figure 4. Schematic drawing of the nuclear STAT3 dimer, indicating the positions of EYFP and Rluc, respectively. (A) EYFP and Rluc are fused to the C-termini (C) of the respective STAT3 monomers. The C-termini are close to each other, and therefore, BRET might occur very efficiently from Rluc to EYFP. (B) Rluc is fused to the N-terminus of one STAT3 monomer and EYFP to the C-terminus of the other STAT3 monomer. As the N-terminus (N) is very elongated in the nuclear dimer, Rluc and EYFP are relatively distant, and therefore, BRET might occur less efficiently than in A.
|
A recent publication by Zhang et al. [10 ] showed an interaction between the N-terminal and the C-terminal domain of STAT3, which was necessary for receptor binding. The authors suggested that this is an intramolecular association between these two domains, which renders the SH2 domain accessible for binding to the receptor. Nevertheless, they cannot exclude that this binding property is also part of an intermolecular association between the STAT3 monomers, which would be favored by our results. Another possibility would be that the intramolecular interaction proposed by Zhang et al. [10 ] leads to a condensed structure of the STAT3 associates, which brings the C-termini and the N-termini into the close proximity necessary for efficient energy transfer.
Based on our data and the findings of Krause et al. [18 ], Zhang et al. [10 ], and Novak et al. [4 ], we suggest a new model of STAT activation, which comprises a latent cytoplasmic dimer and the known activation-induced nuclear dimer (Fig. 5 ). Activation-induced phosphorylation of the STATs renders the cytoplasmic dimer unstable and leads to a reorganization resulting in the formation of the known nuclear dimer. We are aware that this model is highly speculative, but we believe that it could provide a platform for discussion and further research. The conventional model of STAT activation did not provide a satisfying explanation for the dissociation of the STAT molecules from the receptor and for their nuclear transport. It is highly unlikely that a nuclear localization signal is revealed by a dimerization event. The new model might explicate this process more feasibly. Tyrosine phosphorylation of the STAT molecule has been shown to disturb the intramolecular interaction necessary for receptor binding and is therefore likely to provoke dissociation from the receptor. This structural change then probably leads to the formation of the known activation-induced STAT dimer, which is associated via the phosphorylated tyrosine residue and the SH2 domain of the second STAT molecule. It is rather conceivable that this structural change might display a nuclear localization signal, which can be recognized by importin molecules, and leads to the selective nuclear import of the activation-induced STAT dimers.
![]() View larger version (25K): [in a new window] |
Figure 5. A new model of STAT activation. This simplified schematic drawing shows the intramolecular interaction between the C- and the N-terminus (C and N, respectively) of STAT3, which was proposed by Zhang et al. [10
] and suggests a model of receptor-binding of the hypothetical, cytoplasmic STAT dimer. In this dimer, the STAT monomers associate via their C-termini, and the intramolecular interaction between the C-terminus and the N-terminus of one STAT monomer renders the SH2 domain accessible for receptor-binding. After tyrosine phosphorylation, a conformational change occurs, which leads to the formation of the known activation-induced STAT dimers. Jak1, Janus kinase 1; Tyk2, tyrosine kinase 2; Y-P and P-Y, phosphorylated tyrosine residues; SH2, src-homology domain 2; C, C-terminus; N, N-terminus.
|
Further investigation of the structure and function of the proposed cytoplasmic STAT dimers is necessary. An interesting, open question is whether the cytoplasmic STAT molecules actually form dimers or higher-order complexes and whether they only form homogeneous or also heterogeneous complexes with other STAT molecules or other signaling or chaperone proteins. Processes such as receptor-binding and dimerization as well as nuclear translocation of STAT molecules might be strongly connected to the structural change implicated by our model, and its investigation might lead to a better understanding of cytokine signaling.
|
|
|---|
Received October 21, 2003; accepted December 8, 2003.
|
|
|---|
receptor complex in cells Mol. Cell. Proteomics 1,805-815This article has been cited by other articles:
![]() |
L. Li and P. E. Shaw Elevated Activity of STAT3C due to Higher DNA Binding Affinity of Phosphotyrosine Dimer Rather than Covalent Dimer Formation J. Biol. Chem., November 3, 2006; 281(44): 33172 - 33181. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shah, K. Patel, S. Mukhopadhyay, F. Xu, G. Guo, and P. B. Sehgal Membrane-associated STAT3 and PY-STAT3 in the Cytoplasm J. Biol. Chem., March 17, 2006; 281(11): 7302 - 7308. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Neculai, A. M. Neculai, S. Verrier, K. Straub, K. Klumpp, E. Pfitzner, and S. Becker Structure of the Unphosphorylated STAT5a Dimer J. Biol. Chem., December 9, 2005; 280(49): 40782 - 40787. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Grutz New insights into the molecular mechanism of interleukin-10-mediated immunosuppression J. Leukoc. Biol., January 1, 2005; 77(1): 3 - 15. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||